
The FDA asked the maker of weight-loss drug Belviq (lorcaserin) to take it off the market after a clinical trial showed an association with an increased risk of cancer.
from WebMD Health https://ift.tt/2SrsAgb
via IFTTT
The FDA asked the maker of weight-loss drug Belviq (lorcaserin) to take it off the market after a clinical trial showed an association with an increased risk of cancer.
Comments
Post a Comment